Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Granisetron (1mg) Injection
Therapeutic Category
Oncology, Gastroenterology, Anticancer
Dosage Form
Injection
Packaging Type
Vial
Packaging
3mg/3ml
Price
₹111/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Granityle Injection (Granisetron 1mg) is a potent antiemetic medication specifically formulated to prevent and treat nausea and vomiting caused by chemotherapy, radiation therapy, or surgical procedures. Granisetron, the active ingredient in Granityle, belongs to a class of drugs known as 5-HT3 receptor antagonists. It works by blocking the action of serotonin, a neurotransmitter involved in triggering nausea and vomiting. By inhibiting the serotonin receptors in the brain and gastrointestinal tract, Granityle helps to prevent the onset of nausea and vomiting that often accompanies medical treatments such as chemotherapy or major surgeries.
This medication is commonly used in oncology settings, particularly in patients undergoing chemotherapy for cancer, as well as in individuals who experience postoperative nausea and vomiting. It is effective in providing relief from these symptoms, which can severely affect the quality of life and delay recovery. The injection is typically administered under the supervision of a healthcare professional in a clinical setting.
Common side effects include headache, constipation, dizziness, and mild injection site reactions. Serious side effects may include allergic reactions or irregular heartbeat. Seek medical attention if these occur.
Granityle Injection is indicated for the prevention and treatment of nausea and vomiting associated with chemotherapy, radiation therapy, or surgery.
Granityle Injection should only be used under the supervision of a healthcare professional. Consult your doctor before use if you have any known allergies or medical conditions.
Store Granityle Injection at room temperature in a cool, dry place, away from direct sunlight. Keep the vial tightly sealed and out of reach of children.
Composition : Ondansetron (2mg)
Composition : Dicyclomine (20mg/ml) + Diclofenac (50mg/ml)
Composition : Ketorolac (30mg) Injection
Composition : Acetylcysteine (20% w/v) Injection
Composition : Thiocolchicoside (4mg) Injection
Composition : Paracetamol (1000mg) Infusion
Composition : Piroxicam (20mg) Injection
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Granisetron 1mg Injection has strong demand in the anti-emetic and oncology supportive care segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on hospital, chemotherapy, and surgical care portfolios.
Medical distributors and agencies can benefit from consistent demand for management of nausea and vomiting caused by chemotherapy, radiotherapy, and post-operative conditions. Granisetron is a selective 5-HT3 receptor antagonist that helps control severe nausea and vomiting Commonly used in oncology wards, hospitals, and surgical recovery settings This strengthens a reliable hospital-care and critical-care portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Granisetron 1mg Injection with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from hospital demand, oncology prescriptions, post-operative usage, steady institutional sales, reliable supply chain support, and strong margins in critical-care medicines.
Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to discuss pricing, monopoly territory rights, and distribution opportunities.